KEAS-ONCT06868719
Ketone Ester And Salt (KEAS) in Older Adults
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Primary completion pushed from Aug 31, 2027 to Dec 31, 2027v6
- Notable Primary endpoints: 1 to 2
- Enrollment target: 30 to 35
- Primary completion date: Dec 31, 2027 to Aug 31, 2027
- Secondary endpoints: 1 to 5
- Notable Eligibility criteria expanded, about 16 words
- Study description expanded, about 202 words
- Notable Primary endpoints: 6 to 1
- Eligibility criteria shortened, about 1 word
- Secondary endpoints: 5 to 1
- Notable Primary completion date: May 1, 2027 to Dec 31, 2027
- Collaborators: 2 to 3
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (5)
Arms and interventions
Participants will consume each of the supplemental interventions for 10 days (in this assigned order). On Day 10 of each interventional condition, participants will arrive at the laboratory where the investigators will assess resting blood pressure, arterial stiffness, endothelial function, renal blood flow, and submaximal exercise blood pressure reactivity. Blood will be collected to investigate inflammatory and immune responses to the dietary conditions. After a washout period, participants will consume the next assigned supplemental intervention for 10 days, and repeat the Day 10 assessments. After another washout period, participants will consume the final assigned supplemental intervention for 10 days, and again repeat the Day 10 assessments.
Participants will consume each of the supplemental interventions for 10 days (in this assigned order). On day 10 of each interventional condition, participants will arrive at the laboratory where the investigators will assess resting blood pressure, arterial stiffness, endothelial function, renal blood flow, and submaximal exercise blood pressure reactivity. Blood will be collected to investigate inflammatory and immune responses to the dietary conditions. After a washout period, participants will consume the next assigned supplemental intervention for 10 days, and repeat the Day 10 assessments. After another washout period, participants will consume the final assigned supplemental intervention for 10 days, and again repeat the Day 10 assessments.
Participants will consume each of the supplemental interventions for 10 days (in this assigned order). On day 10 of each interventional condition, participants will arrive at the laboratory where the investigators will assess resting blood pressure, arterial stiffness, endothelial function, renal blood flow, and submaximal exercise blood pressure reactivity. Blood will be collected to investigate inflammatory and immune responses to the dietary conditions. After a washout period, participants will consume the next assigned supplemental intervention for 10 days, and repeat the Day 10 assessments. After another washout period, participants will consume the final assigned supplemental intervention for 10 days, and again repeat the Day 10 assessments.
Dietary supplements: No Salt, No β-OHB, High Salt, No β-OHB, High Salt, High β-OHB
Sites
1 site in 1 country
- School of Public HealthBloomington, Indiana, United States